Oncode Scientific

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Updates

3 weeks ago
Happy CNY 2021

May the new year bring in your life joys that never fade, hopes that never die, and strength that never weakens. Wishing you a very happy Chinese New ... See more

3 weeks ago
FDA grants accelerated approval to tepotinib for metastatic non-small

ONCODEcipher Lung Absolute 2.0 NGS Panel comprised of 15 genes (mutation & fusion) including the mentioned MET exon 14 skipping alterations. As well as EGFR, ALK, ROS1, BRAF, KRAS & NTRK1/2/3 which ... See more

Hematology / Oncology News Burst

1 month ago
FDA approves crizotinib for children and young adults with relapsed or

ONCODEcipher Combo NGS Panel comprised of 15 genes (mutation & fusion) including the mentioned ALK, as well as ROS1, BRAF & NTRK1/2/3 which are relevant to young adults relapsed or refractory ... See more

Hematology/Oncology News Burst

2 months ago
Happy New Year 2021

The year of pandemic has shown us what we can bear, it has also taught us endurance, patience and how to break limits. Moving into a new year, we at Oncode laboratory wish that you will be blessed ... See more

2 months ago
Merry Christmas and a Happy New Year!

May the spirit of Christmas infuse your life and that of your family members with hope, positivity and joy. Stay safe, stay healthy, stay positive. Merry Christmas and a Happy New Year!

3 months ago
FDA approves pralsetinib for RET-altered thyroid cancers

ONCODEcipher Combo NGS Panel comprised of 15 genes (mutation & fusion) including the mentioned RET, as well as BRAF, ALK &NTRK1/2/3 which are relevant to thyroid cancer treatment planning. ... See more

Hematology / Oncology News Burst

3 months ago
Happy Diwali

During this festive season of Diwali (The festival of Light), let us lid on a beam of light, warding away bad energy and welcome the beginning of a new (enlightened) path to righteousness. Even the ... See more

4 months ago
Capmatinib shows therapeutic potential for MET-dysregulated advanced NSCLC | Latest news for Doctors, Nurses and Pharmacists | Respirology

NGS/Molecular profiling is particularly important, given the need to test for an increasing number of therapeutically relevant genetic alterations in patients with advanced NSCLC with limited tumour ... See more

Capmatinib shows therapeutic potential for MET-dysregulated advanced NSCLC

5 months ago

Seemingly second wave of covid-19 pandemic is happening now whether we like it or not. With covid-19 positive cases rising day by day, we have to be extra cautious by making sure that we follow ... See more

Scroll to Top